Von Basel in die Welt
die Entwicklung von Geigy, Ciba und Sandoz zu Novartis
| LEADER | cam a22 4 4500 | ||
|---|---|---|---|
| 001 | 274756668 | ||
| 003 | CHVBK | ||
| 005 | 20201024231329.0 | ||
| 008 | 130818s2013 sz 00 ger | ||
| 016 | 7 | |a 1022503278 | |
| 020 | |a 978-3-03823-808-9 |c 48,00 CHF UVP | ||
| 035 | |a (IDSLU)001081980 | ||
| 035 | |a (NEBIS)007576508 | ||
| 035 | |a (ABN)000695862 | ||
| 035 | |a (IDSBB)006048967 | ||
| 035 | |a (RERO)R007203536 | ||
| 035 | |a (VAUD)991017194239702852 | ||
| 035 | |a (ALEX)9914850124101791 | ||
| 035 | |a (SGBN)001161136 | ||
| 035 | |a (GyWOH)har120137019 | ||
| 035 | |a (RNV)007203536-41bculausa_network | ||
| 035 | |a (RERO)007203536 | ||
| 035 | |a R007203536 | ||
| 035 | |a (EXLNZ-41BCULAUSA_NETWORK)991009784069702851 | ||
| 040 | |a SzZuIDS NEBIS ETH-BIB |d SzZuIDS LU LUZHB |e kids | ||
| 072 | 7 | |a s1me |2 rero | |
| 072 | 7 | |a s2ht |2 rero | |
| 082 | 1 | |a 330 |2 15 | |
| 082 | 0 | |a 338.7615190949432 |2 DDC22ger | |
| 100 | 1 | |a Dettwiler |D Walter | |
| 245 | 1 | 0 | |a Von Basel in die Welt |b die Entwicklung von Geigy, Ciba und Sandoz zu Novartis |c Konzept und Text: Walter Dettwiler ; Beiträge: Philipp Gafner ... [et al.] ; [Hrsg.: Novartis International] |
| 264 | 1 | |a Zürich |b Verlag Neue Zürcher Zeitung |c 2013 | |
| 300 | |a 205 S. |b Ill. |c 29 cm | ||
| 490 | 0 | |a NZZ Libro | |
| 500 | |a Register | ||
| 504 | |a Includes bibliographical references and index | ||
| 610 | 2 | 7 | |a J.R. Geigy AG |g Basel |0 (DE-588)1087234360 |2 gnd |
| 610 | 2 | 7 | |a Sandoz AG |0 (DE-588)4051560-6 |2 gnd |
| 610 | 2 | 7 | |a Novartis AG |0 (DE-588)4553029-4 |2 gnd |
| 610 | 2 | 7 | |a CIBA-Geigy AG |0 (DE-588)4129656-4 |2 gnd |
| 610 | 2 | 7 | |a J. R. Geigy AG |0 (DE-588)2016995-4 |2 gnd |
| 610 | 2 | 7 | |a CIBA-Aktiengesellschaft Basel |0 (DE-588)2006998-4 |2 gnd |
| 610 | 2 | 7 | |a Novartis |0 (IDREF)035447486 |2 idref |
| 610 | 2 | 7 | |a Ciba (Bâle) |0 (RERO)A009975752 |2 rero |
| 610 | 2 | 7 | |a Geigy (Bâle) |0 (RERO)A009975754 |2 rero |
| 610 | 2 | 7 | |a Ciba-Geigy (Bâle) |0 (RERO)A009975753 |2 rero |
| 610 | 2 | 7 | |a Sandoz (Bâle) |0 (RERO)A010145853 |2 rero |
| 610 | 2 | 7 | |a Novartis |2 rero |
| 610 | 2 | 7 | |a Ciba (Bâle) |2 rero |
| 610 | 2 | 7 | |a Geigy (Bâle) |2 rero |
| 610 | 2 | 7 | |a Ciba-Geigy (Bâle) |2 rero |
| 610 | 2 | 7 | |a Sandoz (Bâle) |2 rero |
| 610 | 2 | 7 | |a CIBA-Geigy AG |0 (DE-588)2007014-7 |2 gnd |
| 610 | 2 | 7 | |a Novartis AG |0 (DE-588)2163228-5 |2 gnd |
| 610 | 2 | 7 | |a Sandoz AG |g Basel |0 (DE-588)9077-3 |2 gnd |
| 648 | 7 | |a Geschichte |2 gnd | |
| 648 | 7 | |a Geschichte 1758-2012 |2 gnd | |
| 650 | 7 | |a Wirtschaft |0 (DE-588)4066399-1 |2 gnd | |
| 650 | 7 | |a Unternehmen |0 (DE-588)4061963-1 |2 gnd | |
| 650 | 7 | |a ARZNEIMITTELINDUSTRIE + ARZNEIMITTELHANDEL |x ger |0 (ETHUDK)000026591 |2 ethudk | |
| 650 | 7 | |a BASEL, STADT (KANTON BASEL-STADT) |x ger |0 (ETHUDK)000004836 |2 ethudk | |
| 650 | 7 | |a BETRIEBSSFUSIONEN |x ger |0 (ETHUDK)000032245 |2 ethudk | |
| 650 | 7 | |a CHEMIEGESCHICHTE |x ger |0 (ETHUDK)000041563 |2 ethudk | |
| 650 | 7 | |a CHEMISCHE INDUSTRIE |x ger |0 (ETHUDK)000061009 |2 ethudk | |
| 650 | 7 | |a GESCHICHTE DER PHARMAZIE |x ger |0 (ETHUDK)000041242 |2 ethudk | |
| 650 | 7 | |a SCHWEIZ (MITTELEUROPA). SCHWEIZERISCHE EIDGENOSSENSCHAF) |x ger |0 (ETHUDK)000004571 |2 ethudk | |
| 650 | 7 | |a UNTERNEHMENSGESCHICHTE |x ger |0 (ETHUDK)000045768 |2 ethudk | |
| 650 | 7 | |a "1859/2012" |2 ethudk | |
| 650 | 7 | |a Chemieindustrie |0 (DE-STW)12996-0 |2 stw | |
| 650 | 7 | |a Wirtschaftsgeschichte |0 (DE-STW)15706-6 |2 stw | |
| 650 | 7 | |a Histoire |0 (RERO)A021003248 |2 rero | |
| 650 | 7 | |a 19e siècle (2e moitié)-21e siècle (début) |0 (RERO)A023073164 |2 rero | |
| 650 | 7 | |a Histoire |2 rero | |
| 650 | 7 | |a 19e siècle (2e moitié)-21e siècle (début) |2 rero | |
| 650 | 2 | |a Chemical Industry |x history | |
| 650 | 2 | |a Drug Industry |x history | |
| 650 | 7 | |a Chemische Industrie |0 (DE-588)4009848-5 |2 gnd | |
| 650 | 7 | |a Unternehmenszusammenschluss |0 (DE-588)4321280-3 |2 gnd | |
| 651 | 7 | |a Schweiz |0 (DE-588)4053881-3 |2 gnd | |
| 651 | 7 | |a Basel-Landschaft |0 (DE-588)4004619-9 |2 gnd | |
| 651 | 7 | |a Basel-Stadt |0 (DE-588)1077172354 |2 gnd | |
| 651 | 2 | |a Switzerland | |
| 690 | 7 | |B u |a Sandoz AG |2 nebis E2 | |
| 690 | 7 | |B u |a J.R. Geigy AG |2 nebis E2 | |
| 690 | 7 | |B u |a CIBA-Aktiengesellschaft Basel |2 nebis E2 | |
| 690 | 7 | |B u |a Novartis AG |2 nebis E2 | |
| 690 | 7 | |B u |a Chemieindustrie |2 idsbb FC | |
| 690 | 7 | |B u |a Wirtschaftsgeschichte |z Basel-Landschaft, Basel-Stadt |2 idsbb FC | |
| 690 | 7 | |B u |a Geigy |2 idsbb AC | |
| 690 | 7 | |B u |a Ciba |2 idsbb AC | |
| 690 | 7 | |B u |a Sandoz |2 idsbb AC | |
| 690 | 7 | |B u |a Novartis |2 idsbb AC | |
| 690 | 7 | |B u |a CIBA-Aktiengesellschaft |2 idsbb FS | |
| 690 | 7 | |B s |a Wirtschaftsgeschichte |2 alex midonas | |
| 690 | 7 | |B s |a Chemische Industrie |2 alex midonas | |
| 690 | 7 | |B s |a Fusion |2 alex midonas | |
| 690 | 7 | |B g |a Schweiz |2 alex midonas | |
| 690 | 7 | |B g |a Basel |2 alex midonas | |
| 691 | 7 | |B u |u VB 3844 |2 idslu LR | |
| 691 | 7 | |B u |a CHEMISCHE INDUSTRIE |z ger |u 66*1 |2 nebis E1 | |
| 691 | 7 | |B u |a ARZNEIMITTELINDUSTRIE + ARZNEIMITTELHANDEL |z ger |u 615.012%66.09 |2 nebis E1 | |
| 691 | 7 | |B u |a BETRIEBSSFUSIONEN |z ger |u 65,062.14 |2 nebis E1 | |
| 691 | 7 | |B u |a UNTERNEHMENSGESCHICHTE |z ger |u 65,03.06.01(091) |2 nebis E1 | |
| 691 | 7 | |B u |a CHEMIEGESCHICHTE |z ger |u 54(091) |2 nebis E1 | |
| 691 | 7 | |B u |a GESCHICHTE DER PHARMAZIE |z ger |u 615(091) |2 nebis E1 | |
| 691 | 7 | |B u |a BASEL, STADT (KANTON BASEL-STADT) |z ger |u (494.231.1) |2 nebis E1 | |
| 691 | 7 | |B u |a SCHWEIZ (MITTELEUROPA). SCHWEIZERISCHE EIDGENOSSENSCHAFT |z ger |u (494) |2 nebis E1 | |
| 691 | 7 | |B u |u "1859/2012" |2 nebis E1 | |
| 691 | 7 | |B u |a INDUSTRIE CHIMIQUE |z fre |u 66*1 |2 nebis E1 | |
| 691 | 7 | |B u |a CHEMICAL INDUSTRY |z eng |u 66*1 |2 nebis E1 | |
| 691 | 7 | |B u |a PHARMACEUTICAL INDUSTRY + PHARMACEUTICAL TRADE |z eng |u 615.012%66.09 |2 nebis E1 | |
| 691 | 7 | |B u |a INDUSTRIE PHARMACEUTIQUE + COMMERCE DE MÉDICAMENTS |z fre |u 615.012%66.09 |2 nebis E1 | |
| 691 | 7 | |B u |a BUSINESS AMALGAMATIONS |z eng |u 65,062.14 |2 nebis E1 | |
| 691 | 7 | |B u |a FUSION D'ENTREPRISES |z fre |u 65,062.14 |2 nebis E1 | |
| 691 | 7 | |B u |a COMPANY HISTORY |z eng |u 65,03.06.01(091) |2 nebis E1 | |
| 691 | 7 | |B u |a HISTOIRE DE L'ENTREPRISE |z fre |u 65,03.06.01(091) |2 nebis E1 | |
| 691 | 7 | |B u |a HISTORY OF CHEMISTRY |z eng |u 54(091) |2 nebis E1 | |
| 691 | 7 | |B u |a HISTOIRE DE LA CHIMIE |z fre |u 54(091) |2 nebis E1 | |
| 691 | 7 | |B u |a HISTOIRE DE LA PHARMACIE |z fre |u 615(091) |2 nebis E1 | |
| 691 | 7 | |B u |a HISTORY OF PHARMACY |z eng |u 615(091) |2 nebis E1 | |
| 691 | 7 | |B u |a BASEL, CITY (CANTON OF BASEL-STADT) |z eng |u (494.231.1) |2 nebis E1 | |
| 691 | 7 | |B u |a BÂLE, VILLE (CANTON DE BÂLE-VILLE) |z fre |u (494.231.1) |2 nebis E1 | |
| 691 | 7 | |B u |a SUISSE (EUROPE CENTRALE). CONFÉDÉRATION SUISSE |z fre |u (494) |2 nebis E1 | |
| 691 | 7 | |B u |a SWITZERLAND (CENTRAL EUROPE). SWISS CONFEDERATION |z eng |u (494) |2 nebis E1 | |
| 691 | 7 | |B u |u 3.2.4.3.1 |2 idsbb FA | |
| 691 | 7 | |B u |u 658(09) |2 sgbn S1 | |
| 700 | 1 | |a Gafner |D Philipp | |
| 710 | 2 | |a Novartis AG |0 (DE-588)2163228-5 | |
| 852 | 4 | |B IDSBB |F A125 |b A125 |c 125VR |j - |x Holding für Migration per Programm erstellt |a - | |
| 898 | |a BK020000 |b XK020000 |c XK020000 | ||
| 909 | 7 | |a UBFB-201310 |2 nebis EN | |
| 909 | 7 | |a E44ANH-2013 |2 nebis E5 | |
| 909 | 7 | |a ZH |2 idszbz Z1 | |
| 909 | 7 | |a zbzmon201212e |c wuet |d zbzswk201301b |e stet |2 idszbz Z2 | |
| 909 | 7 | |a E19ANH-2013 |2 nebis E5 | |
| 909 | 7 | |a UMHIZ-201507 |2 nebis EN | |
| 909 | 7 | |a NELKSBA1510 |2 abn YA | |
| 909 | 7 | |b basb13 |2 idsbb A | |
| 909 | 7 | |j sarb |2 sgbn S | |
| 909 | 7 | |j sarbu |2 sgbn S | |
| 912 | 7 | |a 300 |2 IDS LU | |
| 912 | 7 | |a E44AR |2 E4420130418 | |
| 912 | 7 | |a ZB3304 |2 Z01 | |
| 912 | 7 | |a 040 |2 E01-20130121 | |
| 912 | 7 | |a 134 |2 E01-20130121 | |
| 912 | 7 | |a 171 |2 E01-20130121 | |
| 912 | 7 | |a E1912 |2 E19-20130708 | |
| 912 | 7 | |a wg |2 SzZuIDS BS/BE | |
| 912 | 7 | |a ww |2 SGBN | |
| 912 | 7 | |a ktm |2 SGBN | |
| 949 | |B IDSBB |F A115 |b A115 |c 115BB |x Exemplarsatz per System ergänzt (Mai 2018) |j - - | ||
| 949 | |B IDSBB |F A150 |b A150 |c 150FH |j ZBS FH K 18/47 | ||
| 949 | |B IDSBB |F A125 |b A125 |c 125F2 |j UBW_NW_6125 4 |x g/2013 | ||
| 949 | |B IDSBB |F A322 |b A322 |c FH |j TPH DQ 201- 1 |x akz:ba/psti/k/NELAA3221212 | ||
| 949 | |B IDSBB |F A342 |b A342 |c FH |j PZB_NW_2435 33 |s PZB Ba 6 80 |x NELA3421303 / A342-k/13 | ||
| 949 | |B IDSBB |F A348 |b A348 |c FH |j STA Bq 649 |x NELA3481306 / Akz.:2012,419 | ||
| 949 | |B IDSBB |F B410 |b B410 |c 410HF |j HIS SW 474 |x NELB4921302 | ||
| 949 | |B IDSBB |F A208 |b A208 |c 208HF |j JF B VIII 146 HF |x BKZ | ||
| 949 | |B IDSBB |F B583 |b B583 |c 583LS |j IMG I 11 GS9 V945 | ||
| 949 | |B NEBIS |F E44 |b E44 |c E44MG |j MCMU B 12860 | ||
| 949 | |B IDSBB |F A125 |b A125 |c 125ST |j SWA H + I Bf 212 (Bro) |x NELA1251212 | ||
| 949 | |B IDSBB |F A298 |b A298 |c PR |j HM Bk qu 163 |x NELA2981212 HMBG2012 | ||
| 949 | |B IDSBB |F A304 |b A304 |c PR |j PHM Ea 482 |x NELA3041806 | ||
| 950 | |B IDSLU |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B IDSLU |P 490 |E 0- |a NZZ Libro | ||
| 950 | |B IDSLU |P 700 |E 1- |a Gafner |D Philipp | ||
| 950 | |B IDSLU |P 710 |E 2- |a Novartis AG |0 (DE-588)2163228-5 | ||
| 950 | |B NEBIS |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B NEBIS |P 490 |E -- |a NZZ Libro | ||
| 950 | |B NEBIS |P 700 |E 1- |a Gafner |D Philipp | ||
| 950 | |B NEBIS |P 710 |E 2- |a Novartis AG |0 (DE-588)2163228-5 | ||
| 950 | |B ABN |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B ABN |P 490 |E 0- |a NZZ Libro | ||
| 950 | |B ABN |P 700 |E 1- |a Gafner |D Philipp | ||
| 950 | |B ABN |P 700 |E 1- |a Vasella |D Daniel | ||
| 950 | |B ABN |P 700 |E 1- |a Billod |D Carole | ||
| 950 | |B ABN |P 700 |E 1- |a Schwarz |D Gerhard | ||
| 950 | |B ABN |P 856 |E -- |u http://d-nb.info/1022503278/04 |z Inhaltsverzeichnis | ||
| 950 | |B ABN |P 856 |E -- |u http://deposit.d-nb.de/cgi-bin/dokserv?id=4041653&prov=M&dok_var=1&dok_ext=htm |z Abstract | ||
| 950 | |B IDSBB |P 490 |E 0- |a NZZ Libro | ||
| 950 | |B IDSBB |P 700 |E 1- |a Dettwiler |D Walter |d 1960- |0 (DE-588)122197267 | ||
| 950 | |B IDSBB |P 700 |E 1- |a Gafner |D Philipp | ||
| 950 | |B IDSBB |P 710 |E 2- |a Novartis AG |0 (DE-588)2163228-5 | ||
| 950 | |B RERO |P 100 |E 1- |a Dettwiler |D Walter |0 (IDREF)171086260 |4 cre | ||
| 950 | |B RERO |P 490 |E 0- |a NZZ Libro | ||
| 950 | |B VAUD |P 100 |E 1- |a Dettwiler |D Walter |4 aut | ||
| 950 | |B VAUD |P 490 |E 0- |a NZZ Libro | ||
| 950 | |B ALEX |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B ALEX |P 700 |E 1- |a Gafner |D Philipp | ||
| 950 | |B ALEX |P 700 |E 1- |a Billod Lochman |D Carole | ||
| 950 | |B SGBN |P 100 |E 1- |a Dettwiler |D Walter | ||
| 950 | |B SGBN |P 490 |E 0- |a NZZ Libro | ||
| 950 | |B SGBN |P 700 |E 1- |a Gafner |D Philipp | ||
| 956 | 4 | |B NEBIS |C ZAD50 |u https://opac.nebis.ch/objects/pdf/z01_978-3-03823-808-9_01.pdf |y Titelblatt und Inhaltsverzeichnis |x VIEW |q pdf | |
| 956 | 4 | |B IDSBB |C DSV51 |D DSV01 |a A100 |u http://www.ub.unibas.ch/tox/IDSBB/006048967/PDF |q pdf |x VIEW |y Inhaltsverzeichnis | |
| 956 | 4 | |B IDSLU |C ILU50 |u https://www.ub.unibas.ch/tox/IDSBB/006048967/PDF |q pdf |x VIEW |y Inhaltsverzeichnis | |
| 986 | |a SWISSBIB |b 020487061 | ||
| 986 | |a ORANGE |b 274756668 | ||